 Kara Mould
Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages, Alveolar | 5 | 2021 | 348 | 1.480 |
Why?
| | Sequence Analysis, RNA | 5 | 2023 | 385 | 1.380 |
Why?
| | Acute Lung Injury | 4 | 2018 | 299 | 1.160 |
Why?
| | Pneumonia | 5 | 2023 | 568 | 0.880 |
Why?
| | Macrophages | 7 | 2023 | 1263 | 0.860 |
Why?
| | Pulmonary Alveoli | 2 | 2021 | 373 | 0.700 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1518 | 0.660 |
Why?
| | Monocytes | 2 | 2023 | 504 | 0.650 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2021 | 590 | 0.620 |
Why?
| | Leukocytes, Mononuclear | 1 | 2021 | 493 | 0.610 |
Why?
| | Inflammation | 8 | 2023 | 2480 | 0.580 |
Why?
| | Sepsis | 1 | 2018 | 509 | 0.410 |
Why?
| | Mice, Inbred C57BL | 6 | 2022 | 4694 | 0.240 |
Why?
| | Healthy Volunteers | 2 | 2022 | 197 | 0.220 |
Why?
| | Folate Receptor 2 | 1 | 2023 | 6 | 0.210 |
Why?
| | Peripheral Tolerance | 1 | 2022 | 14 | 0.200 |
Why?
| | Cytophagocytosis | 1 | 2022 | 10 | 0.200 |
Why?
| | Polyamines | 1 | 2022 | 35 | 0.190 |
Why?
| | Granulomatous Disease, Chronic | 1 | 2022 | 60 | 0.190 |
Why?
| | Granuloma | 1 | 2021 | 83 | 0.180 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2023 | 1140 | 0.180 |
Why?
| | Patient Positioning | 1 | 2021 | 42 | 0.180 |
Why?
| | Animals | 11 | 2022 | 31708 | 0.180 |
Why?
| | Mice | 7 | 2022 | 14871 | 0.170 |
Why?
| | Arginase | 1 | 2019 | 27 | 0.160 |
Why?
| | Cholestenes | 1 | 2018 | 2 | 0.160 |
Why?
| | RNA Precursors | 1 | 2020 | 136 | 0.160 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2019 | 157 | 0.150 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2019 | 81 | 0.150 |
Why?
| | RNA Splicing | 1 | 2020 | 245 | 0.150 |
Why?
| | Alpha-Globulins | 1 | 2018 | 20 | 0.150 |
Why?
| | Interferon-beta | 1 | 2018 | 79 | 0.150 |
Why?
| | CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2018 | 20 | 0.150 |
Why?
| | CD11 Antigens | 1 | 2018 | 30 | 0.150 |
Why?
| | Receptors, Immunologic | 1 | 2019 | 201 | 0.150 |
Why?
| | c-Mer Tyrosine Kinase | 1 | 2017 | 43 | 0.140 |
Why?
| | Respiratory Insufficiency | 1 | 2021 | 290 | 0.140 |
Why?
| | Gene Regulatory Networks | 1 | 2019 | 228 | 0.140 |
Why?
| | Cytokines | 3 | 2023 | 1841 | 0.140 |
Why?
| | Respiration, Artificial | 1 | 2021 | 529 | 0.140 |
Why?
| | Histones | 1 | 2021 | 535 | 0.140 |
Why?
| | Cell-Derived Microparticles | 1 | 2017 | 57 | 0.140 |
Why?
| | Membrane Glycoproteins | 1 | 2019 | 430 | 0.140 |
Why?
| | Hyaluronic Acid | 1 | 2018 | 190 | 0.130 |
Why?
| | Shock, Septic | 1 | 2018 | 186 | 0.130 |
Why?
| | Bleomycin | 1 | 2018 | 228 | 0.130 |
Why?
| | CD11b Antigen | 1 | 2016 | 57 | 0.130 |
Why?
| | Gene Deletion | 1 | 2018 | 356 | 0.130 |
Why?
| | Lipopolysaccharides | 4 | 2023 | 823 | 0.130 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 53 | 0.130 |
Why?
| | Sex Factors | 1 | 2021 | 1715 | 0.130 |
Why?
| | Phagocytosis | 1 | 2017 | 350 | 0.130 |
Why?
| | Phagocytes | 1 | 2016 | 90 | 0.130 |
Why?
| | Cell Lineage | 1 | 2017 | 309 | 0.130 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2017 | 226 | 0.120 |
Why?
| | Recombinant Proteins | 1 | 2018 | 1230 | 0.120 |
Why?
| | Male | 8 | 2022 | 55604 | 0.120 |
Why?
| | Pulmonary Fibrosis | 1 | 2018 | 323 | 0.120 |
Why?
| | Inflammation Mediators | 1 | 2017 | 477 | 0.120 |
Why?
| | Humans | 14 | 2023 | 114696 | 0.110 |
Why?
| | Proto-Oncogene Proteins | 1 | 2017 | 608 | 0.110 |
Why?
| | Antigens, CD | 1 | 2016 | 442 | 0.110 |
Why?
| | Transcriptome | 1 | 2019 | 725 | 0.110 |
Why?
| | Antioxidant Response Elements | 1 | 2013 | 5 | 0.110 |
Why?
| | T-Lymphocytes | 1 | 2021 | 1737 | 0.110 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2013 | 71 | 0.100 |
Why?
| | Metabolomics | 1 | 2017 | 521 | 0.100 |
Why?
| | Cell Proliferation | 1 | 2017 | 2187 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2017 | 2765 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2320 | 0.080 |
Why?
| | Mice, Transgenic | 3 | 2022 | 1950 | 0.080 |
Why?
| | Female | 6 | 2022 | 59518 | 0.080 |
Why?
| | Interleukin-6 | 2 | 2023 | 676 | 0.080 |
Why?
| | Mice, Knockout | 3 | 2022 | 2570 | 0.080 |
Why?
| | HIV-1 | 1 | 2013 | 768 | 0.070 |
Why?
| | B-Lymphocytes | 2 | 2022 | 766 | 0.070 |
Why?
| | Oxidative Stress | 1 | 2013 | 1076 | 0.070 |
Why?
| | Risk Factors | 1 | 2018 | 8632 | 0.060 |
Why?
| | Middle Aged | 2 | 2021 | 26737 | 0.060 |
Why?
| | Lung | 1 | 2016 | 3561 | 0.060 |
Why?
| | Adult | 2 | 2021 | 30552 | 0.050 |
Why?
| | Immunoglobulin Isotypes | 1 | 2022 | 32 | 0.050 |
Why?
| | Immunoglobulin D | 1 | 2022 | 27 | 0.050 |
Why?
| | Spermine | 1 | 2022 | 26 | 0.050 |
Why?
| | Spermidine | 1 | 2022 | 17 | 0.050 |
Why?
| | NADPH Oxidases | 1 | 2022 | 120 | 0.050 |
Why?
| | Interferons | 1 | 2022 | 151 | 0.050 |
Why?
| | Immunomodulation | 1 | 2022 | 84 | 0.050 |
Why?
| | Prone Position | 1 | 2021 | 27 | 0.050 |
Why?
| | Apoptosis | 2 | 2022 | 2363 | 0.050 |
Why?
| | Thrombin | 1 | 2021 | 139 | 0.050 |
Why?
| | RNA, Viral | 1 | 2023 | 565 | 0.040 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2022 | 329 | 0.040 |
Why?
| | Metabolic Networks and Pathways | 1 | 2020 | 168 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2022 | 520 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2018 | 3886 | 0.040 |
Why?
| | Academic Medical Centers | 1 | 2021 | 411 | 0.040 |
Why?
| | Mucociliary Clearance | 1 | 2018 | 42 | 0.040 |
Why?
| | Signal Transduction | 2 | 2022 | 4515 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2018 | 620 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 687 | 0.030 |
Why?
| | Neutrophils | 1 | 2022 | 1176 | 0.030 |
Why?
| | Organ Specificity | 1 | 2016 | 268 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1144 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1352 | 0.030 |
Why?
| | Autoantibodies | 1 | 2022 | 1346 | 0.030 |
Why?
| | Survival Rate | 1 | 2018 | 1644 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2016 | 337 | 0.030 |
Why?
| | Sulfoxides | 1 | 2013 | 2 | 0.030 |
Why?
| | Isothiocyanates | 1 | 2013 | 2 | 0.030 |
Why?
| | Occludin | 1 | 2013 | 10 | 0.030 |
Why?
| | Rats, Transgenic | 1 | 2013 | 15 | 0.030 |
Why?
| | Zonula Occludens-1 Protein | 1 | 2013 | 13 | 0.030 |
Why?
| | Tight Junction Proteins | 1 | 2013 | 9 | 0.030 |
Why?
| | Quinones | 1 | 2013 | 10 | 0.030 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2013 | 31 | 0.030 |
Why?
| | Thiocyanates | 1 | 2013 | 29 | 0.030 |
Why?
| | Claudins | 1 | 2013 | 24 | 0.030 |
Why?
| | Protein Binding | 1 | 2018 | 1890 | 0.030 |
Why?
| | Anticarcinogenic Agents | 1 | 2013 | 67 | 0.030 |
Why?
| | Glutathione | 1 | 2013 | 293 | 0.020 |
Why?
| | RNA Interference | 1 | 2013 | 433 | 0.020 |
Why?
| | Gene Expression | 1 | 2016 | 1421 | 0.020 |
Why?
| | Down-Regulation | 1 | 2013 | 594 | 0.020 |
Why?
| | Biomarkers | 1 | 2018 | 3408 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 6116 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2013 | 2553 | 0.020 |
Why?
| | Rats | 1 | 2013 | 4958 | 0.020 |
Why?
| | United States | 1 | 2021 | 12185 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2021 | 12554 | 0.010 |
Why?
| | Aged | 1 | 2021 | 19074 | 0.010 |
Why?
|
|
Mould's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|